Protroca: A Noninterventional Study on Prophylactic Lipegfilgrastim against Chemotherapy-Induced Neutropenia in Nonselected Breast Cancer Patients.

MLA

Wuerstlein, Rachel, et al. “Protroca: A Noninterventional Study on Prophylactic Lipegfilgrastim against Chemotherapy-Induced Neutropenia in Nonselected Breast Cancer Patients.” Breast Care, vol. 16, no. 1, Jan. 2021, pp. 50–58. EBSCOhost, https://doi.org/10.1159/000506622.

APA

Wuerstlein, R., Harbeck, N., Grischke, E.-M., Forstmeyer, D., von, S. R., Krabisch, P., Lüdtke-Heckenkamp, K., Stefek, A., Stoetzer, O., Grafe, A., Kaltenecker, G., Forstbauer, H., Augustin, D., Schrader, I., Tio, J., Nitz, U., Gluz, O., Kates, R. E., & Graeser, M. K. (2021). Protroca: A Noninterventional Study on Prophylactic Lipegfilgrastim against Chemotherapy-Induced Neutropenia in Nonselected Breast Cancer Patients. Breast Care, 16(1), 50–58. https://doi.org/10.1159/000506622

Chicago

Wuerstlein, Rachel, Nadia Harbeck, Eva-Maria Grischke, Dirk Forstmeyer, Schumann, Raquel von, Petra Krabisch, Kerstin Lüdtke-Heckenkamp, et al. 2021. “Protroca: A Noninterventional Study on Prophylactic Lipegfilgrastim against Chemotherapy-Induced Neutropenia in Nonselected Breast Cancer Patients.” Breast Care 16 (1): 50–58. doi:10.1159/000506622.